Abstract 821: Plasma exosomes are a robust biosignature for prostate cancerChristine Kuslich, David Spetzler, Traci Pawlowski et al.|Cancer Research|2010Cited by 3
Circulating exosomes may provide a more sensitive platform to monitor disease progression compared to circulating tumor cells.Traci Pawlowski, Christine Kuslich, J. Kim et al.|Journal of Clinical Oncology|2010Cited by 2
Abstract 2725: Plasma exosome-based biosignatures: A novel method for early diagnosis of colorectal cancerDavid Spetzler, Christine Kuslich, Traci Pawlowski et al.|Cancer Research|2010Cited by 2
A sensitive exosome-based biosignature for the diagnosis of prostate cancer.Christine Kuslich, David Spetzler, Tingming Deng et al.|Journal of Clinical Oncology|2010Cited by 0
The molecular evolution of prostate cancer cell line exosomes with passage number.David Spetzler, Christine Kuslich, Traci Pawlowski et al.|Journal of Clinical Oncology|2010Cited by 0